K P Economopoulos1, N L Ward2, C D Phillips3,4, A Teshager1, P Patel1, M M Mohamed1, S Hakimian1, S B Cox3, R Ahmed1, O Moaven1, K Kaliannan1, S N Alam1, J F Haller5, A M Goldstein6, A K Bhan7, M S Malo1, R A Hodin1. 1. Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 2. Departments of Molecular Biology and Botany, University of Wyoming, Laramie, WY, USA. 3. Research and Testing Laboratory, Lubbock, TX, USA. 4. Department of Biological Sciences, Texas Tech University, Lubbock, TX, USA. 5. Lipid Metabolism Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 6. Department of Pediatric Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. 7. Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Abstract
AIMS: To examine whether co-administration of intestinal alkaline phosphatase (IAP) with antibiotics early in life may have a preventive role against metabolic syndrome (MetS) in mice. METHODS: A total of 50 mice were allocated to four treatment groups after weaning. Mice were treated with azithromycin (AZT) ± IAP, or with no AZT ± IAP, for three intermittent 7-day cycles. After the last treatment course, the mice were administered a regular chow diet for 5 weeks and subsequently a high-fat diet for 5 weeks. Body weight, food intake, water intake, serum lipids, glucose levels and liver lipids were compared. 16S rRNA gene pyrosequencing was used to determine the differences in microbiome composition. RESULTS: Exposure to AZT early in life rendered mice susceptible to MetS in adulthood. Co-administration of IAP with AZT completely prevented this susceptibility by decreasing total body weight, serum lipids, glucose levels and liver lipids to the levels of control mice. These effects of IAP probably occur as a result of changes in the composition of specific bacterial taxa at the genus and species levels (e.g. members of Anaeroplasma and Parabacteroides). CONCLUSIONS: Co-administration of IAP with AZT early in life prevents mice from susceptibility to the later development of MetS. This effect is associated with alterations in the composition of the gut microbiota. IAP may represent a novel treatment against MetS in humans.
AIMS: To examine whether co-administration of intestinal alkaline phosphatase (IAP) with antibiotics early in life may have a preventive role against metabolic syndrome (MetS) in mice. METHODS: A total of 50 mice were allocated to four treatment groups after weaning. Mice were treated with azithromycin (AZT) ± IAP, or with no AZT ± IAP, for three intermittent 7-day cycles. After the last treatment course, the mice were administered a regular chow diet for 5 weeks and subsequently a high-fat diet for 5 weeks. Body weight, food intake, water intake, serum lipids, glucose levels and liver lipids were compared. 16S rRNA gene pyrosequencing was used to determine the differences in microbiome composition. RESULTS: Exposure to AZT early in life rendered mice susceptible to MetS in adulthood. Co-administration of IAP with AZT completely prevented this susceptibility by decreasing total body weight, serum lipids, glucose levels and liver lipids to the levels of control mice. These effects of IAP probably occur as a result of changes in the composition of specific bacterial taxa at the genus and species levels (e.g. members of Anaeroplasma and Parabacteroides). CONCLUSIONS: Co-administration of IAP with AZT early in life prevents mice from susceptibility to the later development of MetS. This effect is associated with alterations in the composition of the gut microbiota. IAP may represent a novel treatment against MetS in humans.
Authors: Fredrik Bäckhed; Hao Ding; Ting Wang; Lora V Hooper; Gou Young Koh; Andras Nagy; Clay F Semenkovich; Jeffrey I Gordon Journal: Proc Natl Acad Sci U S A Date: 2004-10-25 Impact factor: 11.205
Authors: M Wlodarska; B Willing; K M Keeney; A Menendez; K S Bergstrom; N Gill; S L Russell; B A Vallance; B B Finlay Journal: Infect Immun Date: 2011-02-14 Impact factor: 3.441
Authors: Junhee Seok; H Shaw Warren; Alex G Cuenca; Michael N Mindrinos; Henry V Baker; Weihong Xu; Daniel R Richards; Grace P McDonald-Smith; Hong Gao; Laura Hennessy; Celeste C Finnerty; Cecilia M López; Shari Honari; Ernest E Moore; Joseph P Minei; Joseph Cuschieri; Paul E Bankey; Jeffrey L Johnson; Jason Sperry; Avery B Nathens; Timothy R Billiar; Michael A West; Marc G Jeschke; Matthew B Klein; Richard L Gamelli; Nicole S Gibran; Bernard H Brownstein; Carol Miller-Graziano; Steve E Calvano; Philip H Mason; J Perren Cobb; Laurence G Rahme; Stephen F Lowry; Ronald V Maier; Lyle L Moldawer; David N Herndon; Ronald W Davis; Wenzhong Xiao; Ronald G Tompkins Journal: Proc Natl Acad Sci U S A Date: 2013-02-11 Impact factor: 11.205
Authors: Madhu S Malo; Omeed Moaven; Nur Muhammad; Brishti Biswas; Sayeda N Alam; Konstantinos P Economopoulos; Sarah Shireen Gul; Sulaiman R Hamarneh; Nondita S Malo; Abeba Teshager; Mussa M Rafat Mohamed; Qingsong Tao; Sonoko Narisawa; José Luis Millán; Elizabeth L Hohmann; H Shaw Warren; Simon C Robson; Richard A Hodin Journal: Am J Physiol Gastrointest Liver Physiol Date: 2014-04-10 Impact factor: 4.052
Authors: Samah O Noor; Karyn Ridgway; Louise Scovell; E Katherine Kemsley; Elizabeth K Lund; Crawford Jamieson; Ian T Johnson; Arjan Narbad Journal: BMC Gastroenterol Date: 2010-11-12 Impact factor: 3.067
Authors: Florian Kühn; Ruifeng Duan; Matthias Ilmer; Ulrich Wirth; Fatemeh Adiliaghdam; Tobias S Schiergens; Joachim Andrassy; Alexandr V Bazhin; Jens Werner Journal: Visc Med Date: 2021-04-29
Authors: Matthew T Pereira; Mridu Malik; Jillian A Nostro; Gretchen J Mahler; Laura Palanker Musselman Journal: Dis Model Mech Date: 2018-11-28 Impact factor: 5.758
Authors: Sudha B Singh; Amanda Carroll-Portillo; Cristina Coffman; Nathaniel L Ritz; Henry C Lin Journal: Sci Rep Date: 2020-02-20 Impact factor: 4.379
Authors: Fatemeh Adiliaghdam; Paul Cavallaro; Vidisha Mohad; Marianna Almpani; Florian Kühn; Mohammad Hadi Gharedaghi; Mehran Najibi; Laurence G Rahme; Richard A Hodin Journal: JCI Insight Date: 2020-10-02